Home LiteratureArticle Details
PMID: 10498617 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.

Blood ·Vol. 94 ·No. 7 ·1999-10-01 ·Pages 2445-51

Cameron EE, Baylin SB, Herman JG

Abstract

The promoter region of the cyclin-dependent kinase inhibitor p15(INK4B) contains a CpG island that is hypermethylated in many hematologic malignancies. To explore the relationship between patterns of methylation and gene transcription, we used bisulfite genomic sequencing to obtain a detailed analysis of methylation in acute leukemia, leukemia cell lines, and normal lymphocytes. The entire CpG island region of p15 was largely devoid of methylation in normal lymphocytes, but methylation of varying density was found in primary acute leukemia. Methylation density was generally conserved between the alleles from each sample, but marked heterogeneity for the specific CpG sites methylated was observed. Patterns of methylation were compared and expression assessed with reverse-transcriptase polymerase chain reaction (RT-PCR). The density of methylation within the CpG island, and not any specific location, correlates best with transcriptional loss. Leukemias with methylation of approximately 40% of the CpG dinucleotides on each allele had complete gene silencing, with variable, but diminished expression with less dense CpG island methylation. Our results suggest that the transcriptional silencing of p15 in conjunction with aberrant hypermethylation is best understood as an evolutionary process that involves progressively increasing methylation of the entire p15 CpG island.

MeSH Terms
Base Sequence Carrier Proteins/genetics Cell Cycle Proteins Conserved Sequence Cyclin-Dependent Kinase Inhibitor p15 Cyclin-Dependent Kinase Inhibitor p16 DNA Methylation Dinucleoside Phosphates/metabolism Gene Expression Regulation Gene Expression Regulation, Neoplastic Genes, Tumor Suppressor Humans Leukemia, Myeloid, Acute/genetics Lymphocytes/metabolism Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics Promoter Regions, Genetic Transcription, Genetic Tumor Cells, Cultured Tumor Suppressor Proteins
Chemicals
CDKN2B protein, human Carrier Proteins Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p15 Cyclin-Dependent Kinase Inhibitor p16 Dinucleoside Phosphates Tumor Suppressor Proteins cytidylyl-3'-5'-guanosine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Cameron E E
The Oncology Center, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Baylin S B
Herman J G
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
1999-10-01
Pages
2445-51
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NCI NIH HHS · CA43318 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com